Seed to Sale
FastForward to capitalise on oven-ready opportunities in medical cannabis
FastForward has a 2.3% interest in the issued stock of #EMMAC
FastForward Innovations on FCA’s green light to medical cannabis listings
FCA has set out its approach for UK & overseas-licensed medicinal cannabis companies to be admitted to the Official List in London.
The FCA’s guidance published for medicinal cannabis companies listing on the LSE Official List endorses #FFWD exposure to the sector and strong performance to date.
FastForward Innovations #ffwd is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses, particularly within the #medicalcannabis arena.
The Company’s strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.
who is Europe’s leading producer of medical cannabis products
Emmac Life Sciences Ltd supplier of medical cannabis in Europe.
#EMMAC has a distribution network across all the main European markets, manufacturing capability and a direct-to-patient pharmacy license, multiple take-or-pay contracts for wholesale cannabis, and a portfolio of wellness brands and products.
The company also has a research platform with Imperial College, was the first European cannabis company to sell and export product to Israel and will be launching white-label CBD products in the US.
ffwd share price
8.54 GBX +0.040 (0.47%)
How can I tell whether the FastForward Innovations share price will go up?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it’s worth looking at them when it comes to a share like FastForward Innovations.